Global and Japan Influenza Vaccine Market Insights, Forecast to 2027

Publisher Name :
Date: 03-Sep-2021
No. of pages: 136
Inquire Before Buying

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Global Influenza Vaccine main players include CSL, GSK, Sanofi Pasteur, Mylan, Hulan Bio, AstraZeneca, CCBIO, etc., totally accounting for about 95% of market. North America is the largest market of Influenza Vaccine, with a share over 55%. As for the types of products, it can be divided into Trivalent Influenza Vaccine and Quadrivalent Influenza Vaccine. The most common product is Quadrivalent Influenza Vaccine, with a share over 95%. In terms of applications, it is widely used in For Children (6 months to 3 years) and For Adults and Children over 3 years. The most application is in Adults and Children over 3 years, with a share over 73%.

Market Analysis and Insights: Global and Japan Influenza Vaccine Market

This report focuses on global and Japan Influenza Vaccine market.

In 2020, the global Influenza Vaccine market size was US$ 5154 million and it is expected to reach US$ 6867 million by the end of 2027, with a CAGR of 3.8% during 2021-2027. In Japan the Influenza Vaccine market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Influenza Vaccine Scope and Market Size

Influenza Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For Japan market, this report focuses on the Influenza Vaccine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type

- Trivalent Influenza Vaccine

- Quadrivalent Influenza Vaccine

Segment by Application

- For Children (6 months to 3 years)

- For Adults and Children over 3 years

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- CSL

- GSK

- Sanofi Pasteur

- Mylan

- Hulan Bio

- AstraZeneca

- CCBIO

Global and Japan Influenza Vaccine Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Vaccine Market Size Growth Rate by Type
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market by Application
1.3.1 Global Influenza Vaccine Market Size Growth Rate by Application
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Influenza Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Influenza Vaccine Revenue 2016-2027
2.1.2 Global Influenza Vaccine Sales 2016-2027
2.2 Global Influenza Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Influenza Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Influenza Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Influenza Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Influenza Vaccine Revenue Forecast by Region (2022-2027)
3 Global Influenza Vaccine Competitor Landscape by Players
3.1 Global Top Influenza Vaccine Manufacturers by Sales
3.1.1 Global Influenza Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Influenza Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Influenza Vaccine Manufacturers by Revenue
3.2.1 Key Influenza Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Influenza Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Influenza Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Influenza Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Influenza Vaccine Revenue in 2020
3.2.6 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Influenza Vaccine Price by Manufacturers
3.4 Global Influenza Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Influenza Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Influenza Vaccine Market Size by Type (2016-2021)
4.1.1 Global Influenza Vaccine Sales by Type (2016-2021)
4.1.2 Global Influenza Vaccine Revenue by Type (2016-2021)
4.1.3 Influenza Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Influenza Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Influenza Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Influenza Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Influenza Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Influenza Vaccine Market Size by Application (2016-2021)
5.1.1 Global Influenza Vaccine Sales by Application (2016-2021)
5.1.2 Global Influenza Vaccine Revenue by Application (2016-2021)
5.1.3 Influenza Vaccine Price by Application (2016-2021)
5.2 Influenza Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Influenza Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Influenza Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Influenza Vaccine Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Influenza Vaccine Market Size YoY Growth 2016-2027
6.1.1 Japan Influenza Vaccine Sales YoY Growth 2016-2027
6.1.2 Japan Influenza Vaccine Revenue YoY Growth 2016-2027
6.1.3 Japan Influenza Vaccine Market Share in Global Market 2016-2027
6.2 Japan Influenza Vaccine Market Size by Players (International and Local Players)
6.2.1 Japan Top Influenza Vaccine Players by Sales (2016-2021)
6.2.2 Japan Top Influenza Vaccine Players by Revenue (2016-2021)
6.3 Japan Influenza Vaccine Historic Market Review by Type (2016-2021)
6.3.1 Japan Influenza Vaccine Sales Market Share by Type (2016-2021)
6.3.2 Japan Influenza Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 Japan Influenza Vaccine Price by Type (2016-2021)
6.4 Japan Influenza Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Influenza Vaccine Sales Forecast by Type (2022-2027)
6.4.2 Japan Influenza Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 Japan Influenza Vaccine Price Forecast by Type (2022-2027)
6.5 Japan Influenza Vaccine Historic Market Review by Application (2016-2021)
6.5.1 Japan Influenza Vaccine Sales Market Share by Application (2016-2021)
6.5.2 Japan Influenza Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 Japan Influenza Vaccine Price by Application (2016-2021)
6.6 Japan Influenza Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Influenza Vaccine Sales Forecast by Application (2022-2027)
6.6.2 Japan Influenza Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 Japan Influenza Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Influenza Vaccine Market Size YoY Growth 2016-2027
7.2 North America Influenza Vaccine Market Facts & Figures by Country
7.2.1 North America Influenza Vaccine Sales by Country (2016-2021)
7.2.2 North America Influenza Vaccine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Influenza Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Influenza Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Influenza Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Influenza Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Influenza Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Influenza Vaccine Market Facts & Figures by Country
9.2.1 Europe Influenza Vaccine Sales by Country (2016-2021)
9.2.2 Europe Influenza Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Influenza Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Influenza Vaccine Market Facts & Figures by Country
10.2.1 Latin America Influenza Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Influenza Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Influenza Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Influenza Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Influenza Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Influenza Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 CSL
12.1.1 CSL Corporation Information
12.1.2 CSL Description and Business Overview
12.1.3 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CSL Influenza Vaccine Products Offered
12.1.5 CSL Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Description and Business Overview
12.2.3 GSK Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Influenza Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 Sanofi Pasteur
12.3.1 Sanofi Pasteur Corporation Information
12.3.2 Sanofi Pasteur Description and Business Overview
12.3.3 Sanofi Pasteur Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Pasteur Influenza Vaccine Products Offered
12.3.5 Sanofi Pasteur Recent Development
12.4 Mylan
12.4.1 Mylan Corporation Information
12.4.2 Mylan Description and Business Overview
12.4.3 Mylan Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Mylan Influenza Vaccine Products Offered
12.4.5 Mylan Recent Development
12.5 Hulan Bio
12.5.1 Hulan Bio Corporation Information
12.5.2 Hulan Bio Description and Business Overview
12.5.3 Hulan Bio Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Hulan Bio Influenza Vaccine Products Offered
12.5.5 Hulan Bio Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Corporation Information
12.6.2 AstraZeneca Description and Business Overview
12.6.3 AstraZeneca Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 AstraZeneca Influenza Vaccine Products Offered
12.6.5 AstraZeneca Recent Development
12.7 CCBIO
12.7.1 CCBIO Corporation Information
12.7.2 CCBIO Description and Business Overview
12.7.3 CCBIO Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 CCBIO Influenza Vaccine Products Offered
12.7.5 CCBIO Recent Development
12.11 CSL
12.11.1 CSL Corporation Information
12.11.2 CSL Description and Business Overview
12.11.3 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 CSL Influenza Vaccine Products Offered
12.11.5 CSL Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Influenza Vaccine Industry Trends
13.2 Influenza Vaccine Market Drivers
13.3 Influenza Vaccine Market Challenges
13.4 Influenza Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Influenza Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Influenza Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Trivalent Influenza Vaccine
Table 3. Major Manufacturers of Quadrivalent Influenza Vaccine
Table 4. Global Influenza Vaccine Market Size Growth Rate by Application (2021-2027) & (M Doses)
Table 5. Global Influenza Vaccine Market Size by Region (M Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Influenza Vaccine Sales by Regions (2016-2021) & (M Doses)
Table 7. Global Influenza Vaccine Sales Market Share by Regions (2016-2021)
Table 8. Global Influenza Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Influenza Vaccine Sales Forecast by Region (2022-2027) & (M Doses)
Table 10. Global Influenza Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Influenza Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Influenza Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Influenza Vaccine Sales by Manufacturers (2016-2021) (M Doses)
Table 14. Global Influenza Vaccine Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Influenza Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 16. Influenza Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Influenza Vaccine Revenue Share by Manufacturers (2016-2021)
Table 18. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccine as of 2020)
Table 20. Key Manufacturers Influenza Vaccine Price (2016-2021) (USD/Doses)
Table 21. Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Influenza Vaccine Product Type
Table 23. Date of International Manufacturers Enter into Influenza Vaccine Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Influenza Vaccine Sales by Type (2016-2021) (M Doses)
Table 26. Global Influenza Vaccine Sales Share by Type (2016-2021)
Table 27. Global Influenza Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Influenza Vaccine Revenue Share by Type (2016-2021)
Table 29. Influenza Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Doses)
Table 30. Global Influenza Vaccine Sales Forecast by Type (2022-2027) & (M Doses)
Table 31. Global Influenza Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Influenza Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Influenza Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Influenza Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Doses)
Table 35. Global Influenza Vaccine Sales by Application (2016-2021) (M Doses)
Table 36. Global Influenza Vaccine Sales Share by Application (2016-2021)
Table 37. Global Influenza Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Influenza Vaccine Revenue Share by Application (2016-2021)
Table 39. Influenza Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Doses)
Table 40. Global Influenza Vaccine Sales Forecast by Application (2022-2027) & (M Doses)
Table 41. Global Influenza Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Influenza Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Influenza Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Influenza Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Doses)
Table 45. Japan Influenza Vaccine Sales (M Doses) of Key Companies (2016-2021)
Table 46. Japan Influenza Vaccine Sales Share by Company (2016-2021)
Table 47. Japan Influenza Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan Influenza Vaccine Revenue Share by Company (2016-2021)
Table 49. Japan Influenza Vaccine Sales (M Doses) by Type (2016-2021)
Table 50. Japan Influenza Vaccine Sales Share by Type (2016-2021)
Table 51. Japan Influenza Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan Influenza Vaccine Price (USD/Doses) by Type (2016-2021)
Table 53. Japan Influenza Vaccine Sales (M Doses) by Type (2022-2027)
Table 54. Japan Influenza Vaccine Sales Share by Type (2022-2027)
Table 55. Japan Influenza Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan Influenza Vaccine Revenue Share by Type (2022-2027)
Table 57. Japan Influenza Vaccine Price (USD/Doses) by Type (2022-2027)
Table 58. Japan Influenza Vaccine Sales (M Doses) by Application (2016-2021)
Table 59. Japan Influenza Vaccine Sales Share by Application (2016-2021)
Table 60. Japan Influenza Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan Influenza Vaccine Price (USD/Doses) by Application (2016-2021)
Table 62. Japan Influenza Vaccine Sales (M Doses) by Application (2022-2027)
Table 63. Japan Influenza Vaccine Sales Share by Application (2022-2027)
Table 64. Japan Influenza Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan Influenza Vaccine Revenue Share by Application (2022-2027)
Table 66. Japan Influenza Vaccine Price (USD/Doses) by Application (2022-2027)
Table 67. North America Influenza Vaccine Sales by Country (2016-2021) & (M Doses)
Table 68. North America Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 69. North America Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Influenza Vaccine Sales by Region (2016-2021) & (M Doses)
Table 72. Asia Pacific Influenza Vaccine Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Influenza Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Influenza Vaccine Revenue Market Share by Region (2016-2021)
Table 75. Europe Influenza Vaccine Sales by Country (2016-2021) & (M Doses)
Table 76. Europe Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 77. Europe Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 79. Latin America Influenza Vaccine Sales by Country (2016-2021) & (M Doses)
Table 80. Latin America Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Influenza Vaccine Sales by Country (2016-2021) & (M Doses)
Table 84. Middle East and Africa Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 87. CSL Corporation Information
Table 88. CSL Description and Business Overview
Table 89. CSL Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 90. CSL Influenza Vaccine Product
Table 91. CSL Recent Development
Table 92. GSK Corporation Information
Table 93. GSK Description and Business Overview
Table 94. GSK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 95. GSK Product
Table 96. GSK Recent Development
Table 97. Sanofi Pasteur Corporation Information
Table 98. Sanofi Pasteur Description and Business Overview
Table 99. Sanofi Pasteur Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 100. Sanofi Pasteur Product
Table 101. Sanofi Pasteur Recent Development
Table 102. Mylan Corporation Information
Table 103. Mylan Description and Business Overview
Table 104. Mylan Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 105. Mylan Product
Table 106. Mylan Recent Development
Table 107. Hulan Bio Corporation Information
Table 108. Hulan Bio Description and Business Overview
Table 109. Hulan Bio Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 110. Hulan Bio Product
Table 111. Hulan Bio Recent Development
Table 112. AstraZeneca Corporation Information
Table 113. AstraZeneca Description and Business Overview
Table 114. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 115. AstraZeneca Product
Table 116. AstraZeneca Recent Development
Table 117. CCBIO Corporation Information
Table 118. CCBIO Description and Business Overview
Table 119. CCBIO Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 120. CCBIO Product
Table 121. CCBIO Recent Development
Table 122. Influenza Vaccine Market Trends
Table 123. Influenza Vaccine Market Drivers
Table 124. Influenza Vaccine Market Challenges
Table 125. Influenza Vaccine Market Restraints
Table 126. Influenza Vaccine Customers List
Table 127. Influenza Vaccine Distributors List
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Vaccine Product Picture
Figure 2. Global Influenza Vaccine Sales Market Share by Type in 2020 & 2027
Figure 3. Trivalent Influenza Vaccine Product Picture
Figure 4. Quadrivalent Influenza Vaccine Product Picture
Figure 5. Global Influenza Vaccine Sales Market Share by Application in 2020 & 2027
Figure 6. For Children (6 months to 3 years)
Figure 7. For Adults and Children over 3 years
Figure 8. Influenza Vaccine Report Years Considered
Figure 9. Global Influenza Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Influenza Vaccine Market Size 2016-2027 (US$ Million)
Figure 11. Global Influenza Vaccine Sales 2016-2027 (M Doses)
Figure 12. Global Influenza Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Influenza Vaccine Sales Market Share by Region (2016-2021)
Figure 14. Global Influenza Vaccine Sales Market Share by Region in 2020
Figure 15. Global Influenza Vaccine Revenue Market Share by Region (2016-2021)
Figure 16. Global Influenza Vaccine Revenue Market Share by Region in 2020
Figure 17. Global Influenza Vaccine Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Influenza Vaccine Revenue in 2020
Figure 19. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Influenza Vaccine Sales Market Share by Type (2016-2021)
Figure 21. Global Influenza Vaccine Sales Market Share by Type in 2020
Figure 22. Global Influenza Vaccine Revenue Market Share by Type (2016-2021)
Figure 23. Global Influenza Vaccine Revenue Market Share by Type in 2020
Figure 24. Global Influenza Vaccine Sales Market Share by Application (2016-2021)
Figure 25. Global Influenza Vaccine Sales Market Share by Application in 2020
Figure 26. Global Influenza Vaccine Revenue Market Share by Application (2016-2021)
Figure 27. Global Influenza Vaccine Revenue Market Share by Application in 2020
Figure 28. Japan Influenza Vaccine Sales Growth Rate 2016-2027 (M Doses)
Figure 29. Japan Influenza Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. Japan Influenza Vaccine Market Share in Global Market 2016-2027
Figure 31. Japan 5 and 10 Largest Influenza Vaccine Players Market Share by Revenue in Influenza Vaccine in 2020
Figure 32. Japan Influenza Vaccine Revenue Share by Type (2016-2021)
Figure 33. Japan Influenza Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Japan Influenza Vaccine Revenue Share by Application (2016-2021)
Figure 35. Japan Influenza Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Influenza Vaccine Sales Growth Rate 2016-2021 (M Doses)
Figure 37. North America Influenza Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Influenza Vaccine Sales Market Share by Country in 2020
Figure 39. North America Influenza Vaccine Revenue Market Share by Country in 2020
Figure 40. U.S. Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 41. U.S. Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 43. Canada Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Influenza Vaccine Sales Growth Rate 2016-2021 (M Doses)
Figure 45. Europe Influenza Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Influenza Vaccine Sales Market Share by Country in 2020
Figure 47. Europe Influenza Vaccine Revenue Market Share by Country in 2020
Figure 48. Germany Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 49. Germany Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 51. France Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 53. U.K. Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 55. Italy Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 57. Russia Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Influenza Vaccine Sales Growth Rate 2016-2021 (M Doses)
Figure 59. Asia Pacific Influenza Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Influenza Vaccine Sales Market Share by Region in 2020
Figure 61. Asia Pacific Influenza Vaccine Revenue Market Share by Region in 2020
Figure 62. China Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 63. China Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 65. Japan Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 67. South Korea Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 69. India Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 71. Australia Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. China Taiwan Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 73. China Taiwan Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 75. Indonesia Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 77. Thailand Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 79. Malaysia Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Latin America Influenza Vaccine Sales Growth Rate 2016-2021 (M Doses)
Figure 81. Latin America Influenza Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 82. Latin America Influenza Vaccine Sales Market Share by Country in 2020
Figure 83. Latin America Influenza Vaccine Revenue Market Share by Country in 2020
Figure 84. Mexico Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 85. Mexico Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Brazil Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 87. Brazil Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Argentina Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 89. Argentina Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Middle East and Africa Influenza Vaccine Sales Growth Rate 2016-2021 (M Doses)
Figure 91. Middle East and Africa Influenza Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 92. Middle East and Africa Influenza Vaccine Sales Market Share by Country in 2020
Figure 93. Middle East and Africa Influenza Vaccine Revenue Market Share by Country in 2020
Figure 94. Turkey Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 95. Turkey Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Saudi Arabia Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 97. Saudi Arabia Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. UAE Influenza Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 99. UAE Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Influenza Vaccine Value Chain
Figure 101. Channels of Distribution
Figure 102. Distributors Profiles
Figure 103. Bottom-up and Top-down Approaches for This Report
Figure 104. Data Triangulation
Figure 105. Key Executives Interviewed
  • Global Avian Influenza Vaccines Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 11-Oct-2021        Price: US 3480 Onwards        Pages: 119
    The Avian Influenza Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our lates......
  • Global Encephalitis Vaccination Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 07-Oct-2021        Price: US 3480 Onwards        Pages: 87
    The Encephalitis Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our lates......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 07-Oct-2021        Price: US 3480 Onwards        Pages: 84
    The 23-Valent Pneumococcal Polysaccharide Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. A......
  • Global and United States Meningococcal Conjugate Market Size, Status and Forecast 2021-2027
    Published: 06-Oct-2021        Price: US 3900 Onwards        Pages: 106
    Global Meningococcal Conjugate Scope and Market Size Meningococcal Conjugate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Conjugate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment......
  • Global and China H1N1 Vaccines Market Insights, Forecast to 2027
    Published: 05-Oct-2021        Price: US 3900 Onwards        Pages: 142
    H1N1 Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global H1N1 Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the H1N1 Vaccines market size by ......
  • Global and China Encephalitis Vaccine Market Insights, Forecast to 2027
    Published: 21-Sep-2021        Price: US 3900 Onwards        Pages: 142
    Encephalitis Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Encephalitis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Encephalitis Va......
  • Global Influenza Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 21-Sep-2021        Price: US 3480 Onwards        Pages: 108
    The Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest resea......
  • United States Influenza Vaccine Market Report & Forecast 2021-2027
    Published: 17-Sep-2021        Price: US 3400 Onwards        Pages: 92
    United States Influenza Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses) United States Influenza Vaccine Market Segment Percentages, By Type, 2020 (%) - Trivalent Influenza Vaccine - Quadrivalent Influenza Vaccine United States Influenza Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses) United States Influenza Vaccine Market Segment Percentages, By Application, 2020 (%) - For Children (6 months to......
  • 2021-2027 Global and Regional 23-Valent Pneumococcal Polysaccharide Vaccine Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 13-Sep-2021        Price: US 3500 Onwards        Pages: 140
    The global 23-Valent Pneumococcal Polysaccharide Vaccine market was valued at 1986.07 Million USD in 2020 and will grow with a CAGR of 14.57% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(N......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs